Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 3, 2026 FORM 4
4 Mar 20, 2026 FORM 4
4 Feb 27, 2026 FORM 4
144 Feb 10, 2026
10-Q Feb 6, 2026 10-Q
8-K Feb 6, 2026 8-K
4 Jan 23, 2026 FORM 4
4 Jan 9, 2026 FORM 4
4 Dec 19, 2025 FORM 4
SCHEDULE 13D/A Dec 12, 2025
4 Dec 12, 2025 FORM 4
8-K Dec 12, 2025 8-K
424B5 Dec 12, 2025 424B5
8-K Dec 11, 2025 8-K
FWP Dec 11, 2025 FWP
4 Dec 3, 2025 FORM 4
4 Dec 3, 2025 FORM 4
144 Dec 1, 2025
144 Dec 1, 2025
144 Nov 26, 2025
144 Nov 25, 2025
4 Nov 21, 2025 FORM 4
← Newer Page 3 of 26 · 641 filings Older →